Abstract LB-C13: Selective GPR55 antagonism attenuates EGFR-PKM2-β-catenin signaling and reduces chemoresistance in PANC-1 pancreatic cancer cells
Year: 2015
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2397174609
